Current gene therapy protocols often suffer from an inability to monitor the site, level and persistence of gene expression following somatic DNA delivery. Herpes simplex virus 1 thymidine kinase (HSV1-tk) is currently under intensive investigation as a reporter gene for in vivo imaging of reporter gene expression. The presence of the HSV1-tk reporter gene is repetitively and non-invasively monitored by systemic injection of positron-emitting, radionuclide-labeled thymidine analogues or acycloguanosine HSV1-TK substrates and subsequent detection, by positron emission tomography, of trapped, phosphorylated product. To improve the efficacy of the HSV1-tk PET reporter gene system, both alternative substrates and mutations in the HSV1-tk gene have been described. We used a replication defective adenovirus to deliver the HSV1-sr39tk mutant enzyme and the wild-type HSV1-tk enzyme to mice. HSV1-sr39TK demonstrates greater sensitivity than wild-type HSV1-TK enzyme in vivo, using 9-[(4-[
Introduction
A variety of viral and non-viral vectors are currently in development as therapeutic modalities for targeted somatic DNA transfer. Reporter genes such as bgalactosidase, alkaline phosphatase, firefly luciferase (FL) and green fluorescent protein (GFP) have facilitated these investigations by providing rapid, convenient and inexpensive assays to monitor the location, magnitude and duration of gene expression following somatic DNA transfer. However, the vast majority of studies performed in animal models to optimize vector targeting and functional gene delivery utilize protocols that require that the animals be killed to monitor reporter gene expression. Recently, however, a number of non-invasive technologies for monitoring reporter gene expression in vivo have been described. These technologies hold out the promise of non-invasive, repetitive and quantitative analysis of the location, magnitude and duration of reporter gene expression. We recently reviewed reporter gene technologies to monitor gene expression. 1 Advances in the imaging of both GFP 2, 3 and FL 4 for in vivo studies, using optical imaging devices, have made possible the use of optical techniques to analyze, in real time, reporter gene expression in small animals such as mice. Although imaging reporter gene expression by optical techniques has attenuation, scatter and resolution limitations, it is convenient, fast and relatively inexpensive. However, the potential use of in vivo optical imaging of reporter genes such as FL and GFP is substantially limited in humans, due to attenuation of visible light.
Positron-emitting radioisotope-based imaging technologies have also been applied to in vivo reporter gene imaging. One such in vivo gene imaging approach has used, as reporter genes, genes that encode receptors. Expression of the reporter gene product is measured by sequestration in target tissue of radiolabeled ligand. 6 labeled ligands, using single photon imaging. The dopamine D2 receptor (D2R), which is normally expressed only in the striatum, can be ectopically expressed and subsequently detected by using a positron-emitting radiolabeled D2R ligand, 3-(2 0 -18Ffluoroethyl)spiperone (FESP). MicroPET (a small animal positron emission tomograph (PET) scanner 7 ) can be used, following systemic FESP injection, to image hepatic D2R reporter gene expression in mice injected with an adenovirus in which the D2R is driven by a cytomegalovirus promoter. 8 A second approach to in vivo imaging uses enzymes as reporter genes and radiolabeled substrates as reporter probes that are converted to sequestered forms by the activities of the reporter enzymes. The most popular enzyme reporter gene is herpes simplex virus 1 thymidine kinase (HSV1-tk). HSV1-TK, like mammalian thymidine kinases, phosphorylates thymidine. However, HSV1-TK is also able to effectively utilize as substrates acycloguanosine antiviral agents such as acyclovir, ganciclovir and penciclovir as well as thymidine derivatives such as 2 0 -fluoro-2 0 -deoxy-1-b-D-arabinofuranosyl-5-iodouracil (FIAU). Many of these substrates have been labeled with positron-emitting isotopes [9] [10] [11] and used to image HSV1-tk gene expression by PET, in both somatic gene transfer [12] [13] [14] [15] and transgenic mouse 10, 16 models. Mutagenesis of the HSV1-tk active site was used to create, for therapeutic purposes, mutants that are more effective than the wild-type HSV1-TK enzyme at using acyclovir and ganciclovir as a substrate and less effective at using endogenous thymidine. 17 We reasoned that HSV1-TK mutants that more effectively utilize acycloguanosines as substrates might also use positron-emitting radiolabeled acycloguanosine analogues more effectively as reporter probes. Using both replicationdefective adenoviruses to deliver HSV1-tk and the mutant HSV1-sr39tk genes to murine liver as well as tumor xenografts bearing HSV1-tk and HSV1-sr39tk, we demonstrated that HSV1-sr39TK more effectively utilizes 8-18Ffluoro-9-4-hydroxy-3-(hydroxymethyl)but-1-ylguanine (fluoropenciclovir or FPCV) as a PET reporter probe than does HSV1-tk. 18 Recently, 9-[(4-[ 18 F]-fluoro-3-hydroxymethylbutyl)guanine (FHBG) has been suggested to be a more effective probe for in vivo imaging of the wildtype HSV1-tk PET reporter gene. 19 We find, using mice injected with a replication-defective adenovirus expressing the HSV1-sr39tk gene from a cytomegalovirus promoter, that FHBG is a more effective imaging probe than FPCV. We demonstrate the utility of HSV1-sr39tk and FHBG as a reporter system to non-invasively, quantitatively and repetitively monitor the location, magnitude and duration of reporter gene expression over a 3-month period following adenoviral somatic gene transfer.
Results
C6 cells infected with recombinant adenoviruses ad. TKm (delivering the mutant HSV1-sr39tk gene) and ad.TK (delivering the wild-type HSV1-tk gene) produce similar amounts of viral thymidine kinase protein
To compare the levels of TK protein synthesized from ad.TKm and ad.TK infected cells, 5 Â 10 6 C6 cells (in 100 mm plates) were infected with two viral titers (1 Â 10 6 and 1 Â 10 8 pfu) of each virus. Cell extracts prepared 24 h after viral infection were subjected to Western blot analysis with a polyclonal antibody against HSV1-TK. 17 The blots were then stripped and reprobed with an antiserum to GAPDH. Qualitatively, the TK bands produced by ad.TKm infected cells are similar to those from ad.TK infected cells (Figure 1 6 , the retention of radioactive substrate levels off for ad.TKm infected cells (data not shown). At this level of infection, the C6 cells infected with ad.TKm sequester about 65-70% of available substrate; it seems likely that -at this point -availability of substrate becomes limiting.
HSV1-sr39tk provides a strong improvement in reporter gene activity, in comparison with HSV1-tk, following in vivo injection of ad.TK. and ad.TKm
We compared HSV1-tk and HSV1-sr39tk as reporter genes for in vivo imaging, using both FPCV and FHBG as probes, when these two reporter genes were delivered by the recombinant adenoviruses ad.TK and ad.TKm. Swiss Webster mice were injected by tail vein with 1 Â 10 9 pfu of control virus (ad.v; six mice), virus expressing HSV1-tk (ad.TK; six mice) or virus expressing HSV1-sr39tk (ad.TKm; six mice). Two days later, three mice from each group were injected by tail vein with FPCV and the three remaining mice were injected with FHBG. After an additional hour, one mouse from each group was scanned by microPET. Using FPCV as reporter probe (Figure 4a ), the FPCV retention in the liver resulting from expression of the HSV1-tk reporter gene is 8.5% of the injected FPCV dose per gram of liver, estimated by region of interest (ROI) measurement. The FPCV retention in the liver resulting from expression of the HSV1-sr39tk reporter gene is 13.3% of the injected FPCV dose per gram of liver. Using FHBG as reporter probe ( Figure  4b ), 22.6% of the injected FHBG is retained per gram of liver in mice infected with virus expressing the mutant HSV1-sr39TK, using ROI analysis. In contrast, ROI analysis suggests only 9.2% of the injected FHBG is retained per gram of liver in mice infected with virus expressing the wild-type HSV1-tk reporter gene.
After scanning one mouse from each group, all the mice were sacrificed and the livers were sampled for direct measurement of tracer retention. With FPCV as probe, mice expressing HSV1-sr39TK retain 13.272.7% injected dose (ID)/g liver, which is significantly greater (P o 0.05) than that (7.372.4% ID/g liver) retained by mice expressing HSV1-TK ( Figure 5 ). Using FHBG as reporter probe, an even greater improvement in sensitivity was observed for the mutant HSV1-sr39TK reporter gene. FHBG retention is substantially greater (P o 0.01) in livers of mice injected with ad.TKm (21.970.7% ID/g liver) as compared with ad.TK (9.071.9% ID/g liver). The data demonstrate that FHBG is a better reporter probe than FPCV when HSV1-sr39tk is used as a reporter gene. The mutant HSV1-sr39tk enzyme is clearly a substantially better reporter gene than its wild-type counterpart, following adenovirusmediated somatic gene transfer, using either positronemitting, radiolabeled acycloguanosine substrate.
Expression of HSV1-sr39tk can be repetitively imaged by microPET over a 3 month period in Swiss Webster mice injected with ad.TKm Three. 12-week old male Swiss Webster mice were injected via the tail-vein with 2 Â 10 9 pfu of ad.TKm. Three days later, the first round of microPET scanning was performed on these mice. Each mouse demonstrated a strong hepatic image. The average FHBG retention for these three mice in their first imaging session is 16.670.5% ID/g liver (Figure 6b ). We carried out repetitive microPET scans each week on these three mice for 3 weeks after the first round of PET imaging. For the first week scans (10 days after the viral injection), the expression of HSV1-sr39tk declined to an average FHBG retention of 11.370.4% ID/g liver. However, for the second week scans (17 days after the viral injection) and In vivo imaging with mutant HSV1-tk reporter Q Liang et al the third week scans (24 days after the viral injection), the expression of HSV1-sr39tk remained essentially constant, averaging 10.970.5% and 10.771.9% ID/g liver respectively. We monitored HSV1-sr39tk expression levels in these three mice by microPET scanning for two additional months. The HSV1-sr39tk expression level in the mice went down relatively slowly. In the second month scanning (58 days after the viral injection), the average FHBG retention in the three mice was 7.271.5% ID/g liver. In the third month scanning (88 days after the viral injection), the average FHBG retention was 5.6+1.0% ID/g liver. Repetitive scans on the same mouse at all time points are shown in Figure  6a . Three days after the last microPET scan (91 days after the viral injections), the three mice were sacrificed and the amounts of HSV1-sr39TK in their livers were evaluated by Western blot (Figure 6c ). All three mice still had easily detectable levels of HSV1-sr39TK protein in their livers.
Discussion
Non-invasive, repetitive imaging of reporter gene expression should provide a valuable new tool for the analysis of therapeutic somatic gene transfer, enabling researchers and clinical practitioners to monitor the location, magnitude and duration of gene expression following gene transfer. Currently, the somatostatin receptor gene 5, 6 the HSV1-tk gene [9] [10] [11] [12] [13] [14] [15] and the D2R gene 8, 20 have been the subject of the most extensive analyses for in vivo reporter gene development, using positron-emitting, radiolabeled probe detection systems.
Utility of HSV1-tk as an in vivo reporter gene whose product is monitored by sequestration of a positronemitting, radiolabeled substrate has been improved both by modifying the substrates of the enzyme and by modifying the gene itself, to develop a mutant enzyme that can more effectively utilize alternative substrates. 14, 15 We also investigated the utility of FPCV, and found FPCV to be a substantially better PET reporter probe than FGCV for imaging HSV1-tk gene expression. 23 Alauddin et al 24 (FHPG), and tested FHPG as an imaging probe in vivo to monitor the level of ectopically expressed HSV1-tk. 25 FHPG has subsequently been tested in several laboratories, 26, 27 and shown to be an effective reporter probe to image HSV1-tk in xenografted tumors following intravenous tracer injection. However, a recent study has suggested that [ 124 I]-FIAU is a more effective substrate to image wildtype HSV1-tk than is FHPG. 28 Alauddin and Conti 19 suggested that side chain labeled penciclovir might be a better imaging substrate than FHPG. These authors synthesized FHBG, the sidechain fluorinated analogue of penciclovir, but did not describe its use for PET imaging. However, their cell culture studies with FHPG 25 and FHBG 19 strongly suggested that FHBG would be a better HSV1-tk imaging probe.
HSV1-tk has been extensively investigated as a therapeutic gene, because of its ability to convert acycloguanosine prodrugs to toxic forms when these compounds are delivered at pharmacologic levels to cells expressing the enzyme. To improve the efficacy of HSV1-tk as a therapeutic gene, Black et al, 17 identified mutant HSV1-TK enzymes that are more effective than the wild-type enzyme in phosphorylating ganciclovir and have a reduced ability to utilize thymidine as substrate. We reasoned that these mutant HSV1-TK enzymes might also be more effective than wild-type TK in phosphorylating positron-emitting, radioabeled acycloguanosines, and used cell culture assays and stably transformed tumor cell lines carrying the transfected HSV1-sr39tk mutant gene to demonstrate that FGCV and FPCV are more effectively phosphorylated by HSV1-sr39TK than by wild-type TK. 18 These data suggest that the HSV1-sr39tk/FHBG PET reporter gene/PET reporter probe imaging system might be an improved system for monitoring somatic gene transfer in living individuals. We tested this proposal by examining the efficacy of the HSV1-sr39tk gene as a PET reporter probe in a replication-defective adenoviral gene delivery model. This prediction is borne out; when equivalent titers of ad.TKm (delivering HSV1-sr39TK) and ad.TK (delivering HSV1-TK) are injected intravenously into mice, HSV1-sr39TK is two-to three-fold more effective than HSV1-TK as a reporter gene, utilizing FHBG as substrate. The combination of HSV-sr39tk as PET reporter gene and FHBG as PET reporter probe is about an order of magnitude more effective, in vivo, than our original combination of wild-type HSV1-tk and FGCV. 14, 15 Brust et al 28 demonstrated that the reporter gene/reporter probe HSV1-tk/[
124 I]-FIAU is a more effective imaging system than is the HSV1-tk/FHPG system, using a human tumor xenograft model. We have shown that HSV1-sr39tk is a better PET reporter gene than is wild-type HSV1-tk, using a variety of fluorinated acycloguanosines, both in cell culture and in vivo (Figures 2 and 5 , and Ref. 18) . FHBG is a more effective substrate than FHPG for HSV1-TK. 19, 24, 25 We have recently demonstrated, in human volunteers, that FHBG has properties that suggest it will be an excellent imaging probe for HSV1-TK-based PET reporter genes. 29 It will now be of great interest to compare the HSV1-tk/[
124 I]-FIAU and HSV1-sr39tk/FHBG imaging systems.
Using DNA family shuffling, Christians et al, 30 have recombined the HSV1 and HSV2 thymidine kinase genes in vitro and identified chimeric enzymes with enhanced ability to phosphorylate AZT. It should be possible, using these same techniques, to further improve the imaging capability of HSV1-tk PET reporter genes by developing chimeric enzymes that use FIAU and/or FHBG more effectively.
Using the HSV1sr39TK enzyme and FHBG as reporter probe, we find that somatic gene transfer from an adenoviral vector can be non-invasively, quantitatively and repetitively monitored in vivo, and can report the location, magnitude and duration of reporter gene Figure 5 Comparison of FPCV and FHBG retained by livers of ad.TK and ad.TKm infected mice. Groups of three Swiss Webster mice were injected intravenously with ad.v (two groups), ad.TK (two groups) or ad.TKm (two groups). Each mouse received 1 Â 10 9 pfu. Forty-eight hours later, one group injected with each virus was injected with FPCV and one group injected with each virus was injected with FHBG. Two hours later, the animals were sacrificed and liver samples were collected and weighed. Radioactivity in each liver sample was measured. The results are shown as means 7 standard errors of three mice. *, FPCV % ID/g liver retained by mice receiving HSV1-sr39TK is significantly greater (P o0.05) than FPCV % ID/g liver retained by mice receiving HSV1-TK; **, FHBG % ID/g liver retained by mice receiving HSV1-sr39TK is significantly greater (P o0.01) than FHBG % ID/g liver retained by mice receiving HSV1-TK.
In vivo imaging with mutant HSV1-tk reporter Q Liang et al expression. The results documented here should be generalizable to other viral DNA delivery vectors as well as to non-viral vectors used for somatic gene delivery. By incorporating this reporter system into bicistronic 31 and bi-directional 32 dual expression DNA delivery vectors, it should be possible to monitor the location, magnitude and duration of expression for reporter genes in somatic cell DNA transfer experiments, and to then infer the relative expression of therapeutic genes present in the same DNA delivery vector. [8- 3 H]-PCV (14.9 Ci/ mmol) were purchased from Moravek Biochemicals (La Brea, CA, USA). MicroPET reporter tracer probes FPCV (2-5 Ci/mmol) and FHBG (B1000Ci/mmol) were synthesized and purified as described previously. 23, 19 Swiss Webster mice were from Simonsen Labs (Gilroy, CA, USA).
Materials and methods

Materials
Construction and purification of recombinant adenovirus
A mutant herpes simplex virus type 1 thymidine kinase cDNA (HSV1-sr39tk) in vector pET23d.SR39. was a gift from Dr Margaret Black. 17 The coding region of the HSV1-sr39tk (1. 
CAAGCTTCCGGTATTGTCTCCT 3
0 . The PCR product was cloned into vector pCRII (Invitrogen, Carlsbad, CA, USA), and analyzed by DNA sequencing. No undesired mutation was observed in the HSV1-sr39tk coding sequence. The confirmed coding sequence was cloned into adenovirus shuttle vector pACCMVpLpASR(+) 33 and the resulting construct was designated as pACCMV.TKm. The expression of HSV1-sr39tk from the CMV promoter of pACCMV.TKm was analyzed by Western blot and thymidine kinase assay after transient transfection of the plasmid into rat C6 glioma cells. To construct recombinant adenovirus expressing HSV1-sr39tk, the shuttle vector pACCMV.TKm was co-transfected with Ad5 genome plasmid pJM17 (Microbix Biosystems Inc., Ontario, Canada) into 293 cells. Plaques Figure 6 Repetitive, quantitative monitoring of HSV1-sr39tk expression in ad.TKm injected mice, using microPET, for a period of 3 months. Three Swiss Webster mice were tail-vein injected with ad.TKm (2 X 10 9 pfu). Three days later, FHBG injections and microPET scanning were carried out to monitor the expression of the HSV1-sr39tk reporter gene. FHBG injection and microPET analysis was repeated six times for each mouse in an 88 day period. 14 and a control replication-deficient adenovirus (ad.v) 20 were also used in experiments reported here.
Cell culture DME high-glucose medium supplemented with 10% fetal bovine serum, 0.2 mM. glutamine, 110 mg/L sodium pyruvate, 100 units/ml penicillin and 100 mg/ml streptomycin was used to culture 293 cells and C6 cells. Transient transfection was carried out with Superfect reagent (Qiagen Inc., Valencia, CA, USA) as described by the manufacturer. Co-transfection to produce recombinant adenovirus was performed by the calcium phosphate precipitation method. 34 
Western blot analysis
Cells or mouse liver were lysed in buffer (pH 7.5). containing 20 mM potassium phosphate, 0.5% Triton X-100 and 1 X protease inhibitor cocktail (Roche Diagnostics Corporation, Indianapolis, IN, USA) by 30 s of sonication. Protein concentrations of supernatants from a 16 000 g centrifugation were determined using the BioRad Protein Assay (Bio-Rad Laboratories, Hercules, CA, USA). For each sample, 20 mg of protein extract was loaded onto a 10% SDS-PAGE gel. After electrophoresis, proteins on the gel were transferred to nitrocellular membranes. Rabbit polyclonal antiserum to HSV1-TK, 17 a gift from Margaret Black, was used to detect the viral thymidine kinase on the membranes. Protein loading was examined using an anti-GAPDH antiserum (Chemicon, Inc., Temecula, CA, USA). The signal on the Western blot was visualized with an enhanced chemiluminescence (ECL) kit (Amersham Life Science, Piscataway, NJ, USA), and recorded on Kodak film (Eastman Kodak Company, Rochester, NY, USA). The Western blot bands of TK and GAPDH were quantitated by using the computer program NIH Image 1.61/fat (performed using the public domain NIH Image program developed at the U.S. National Institutes of Health and available on the Internet at http://rsb.info.nih.gov/nih-image).
Thymidine kinase assay
The assays were performed as described previously. 14, 18 One microgram of cell extract was incubated with HSV1-TK substrate [8- H]-PCV was added in 500 ml medium. After 4 h at 37 o C, the medium was removed and cells were washed twice with 1 ml of PBS. The cells were then harvested by scraping and spun at 5000 Â g in a benchtop centrifuge for 2 m. The cell pellets were lysed in 500 ul buffer (1 Â PBS, 0.3% SDS) by a 30 s sonication. After a 15 min centrifugation at full speed in a benchtop centrifuge, the protein concentration in the supernatant was determined using the Bio-Rad Protein Assay Reagent. The radioactivity in each sample was measured in a scintillation counter.
MicroPET imaging of mice
Recombinant adenoviruses expressing HSV1-tk or the mutant HSV1-sr39tk from the CMV promoter were injected by tail vein into 10-15-week old male Swiss Webster mice (30-35 g ). For microPET imaging, mice were anesthetized by i.p. injection of ketamine/xylazine 20 and injected via tail vein with FHBG (150-250 mCi) or FPCV (B200 mCi). After 1 h, mice were anesthetized and scanned by microPET 7 in the prone position with the long axis of the mouse parallel to the long axis of the scanner. Each scan required about 30 min (4 min per bed position, seven bed positions). MicroPET images were reconstructed either by filtered back projection 14 or by using an iterative reconstruction technique. 35 Quantitation of fluorine-18 retention in murine liver by microPET image analysis ROI were drawn over the liver image (left, front and right lobes) on decay-corrected whole-body coronal images of each mouse. The counts per pixel/min obtained from the ROI were converted to counts per ml/min by using a calibration constant obtained from scanning a cylinder phantom of known activity concentration in the microPET scanner. The ROI counts per ml/ min were converted to counts per g/min, assuming a tissue density of 1 g/ml, and divided by the injected dose to obtain an image ROI-derived percent injected dose of fluorine-18 tracer retained per gram of liver (% ID/g liver).
Measurement of tracer retention in mouse liver
Two hours after the injection of FHBG or FPCV, mice that had received virus 2 days previously were killed and three pieces (0.2-0. 3 g) of liver tissue were dissected from the left, center and the right liver lobes. After weighing, 18 F radioactivity in the liver sample was measured in a Model 1185 Searle Well Counter (Searle Analytic, Des Plains, IL, USA). Flourine-18 retention was calculated from these readings, after correction for counting efficiency and calibration of fluorine-18 decay. award P50 CA86306 (HRH, MEP, SSG, JRB, NS), NIH award R0-1 CA84572 (HRH) and NIH award R0-1 CA82214-01 (SSG).
